{"id":137,"date":"2026-02-28T07:16:27","date_gmt":"2026-02-28T07:16:27","guid":{"rendered":"https:\/\/drmandeepsinghmalhotra.com\/blogs\/?p=137"},"modified":"2026-02-28T08:13:26","modified_gmt":"2026-02-28T08:13:26","slug":"robotic-revolution-in-gynecologic-oncology-cancer-surgery-in-india","status":"publish","type":"post","link":"https:\/\/drmandeepsinghmalhotra.com\/blogs\/robotic-revolution-in-gynecologic-oncology-cancer-surgery-in-india\/","title":{"rendered":"Robotic Revolution in Gynecologic Oncology: How Dr. Parminder kaur mentored by Dr Mandeep Is Transforming the Surgical Care of Uterine, Cervical &amp; Ovarian Cancers"},"content":{"rendered":"\n<p><em>An Overview of Gynecologic Cancers, Their Management and the Role of Robotic Surgery in Delhi NCR India<\/em><\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>About Dr Parminder Kaur<\/strong><\/h2>\n\n\n\n<p>Dr. Parminder Kaur&nbsp; is a recent addition to&nbsp; Dr Mandeep&#8217;s team. She is a certified <strong>gynecologic oncologist in Delhi NCR<\/strong> with extensive experience in both conventional and laproscopic surgery. <strong><a href=\"https:\/\/drmandeepsinghmalhotra.com\/cancer-oncologist-surgeon-in-india.html\">Dr Mandeep<\/a><\/strong> has mentored her in acquiring skills of Robotic surgery. Renowned for her technical expertise and compassionate patient care, she combines cutting\u2011edge technology with a deep understanding of women\u2019s health to provide optimal outcomes for patients with malignancies of the female reproductive tract.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Know about Gynecologic Cancers \u2013 Spectrum and Clinical Presentation<\/strong><\/h2>\n\n\n\n<p>Gynecologic malignancies arise from the organs of the female reproductive system, namely:<\/p>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><td><strong>Organ<\/strong><\/td><td><strong>Common Cancer Types<\/strong><\/td><\/tr><\/thead><tbody><tr><td>Uterus (Endometrium)<\/td><td>Endometrial carcinoma<\/td><\/tr><tr><td>Cervix<\/td><td>Cervical carcinoma<\/td><\/tr><tr><td>Ovaries &amp; Fallopian Tubes<\/td><td>Epithelial ovarian carcinoma, primary tubal carcinoma<\/td><\/tr><tr><td>Vagina<\/td><td>Vaginal carcinoma (rare)<\/td><\/tr><tr><td>Vulva<\/td><td>Vulvar carcinoma (rare)<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>Epidemiology<\/strong><\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li>In India, cervical cancer (India alone reported 127,526 new cases and 79,906 fatalities in 2022, contributing 29.59 % of global cervical cancer cases and 34.12 % of deaths. ) remains the most common gynaecologic malignancy, whereas in many Western populations endometrial cancer predominates.<\/li>\n\n\n\n<li>Although most cancers are diagnosed in post\u2011menopausal women, a significant proportion of ovarian and, occasionally, cervical cancers affect younger women.<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>Typical Symptoms<\/strong><\/h3>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><td><strong>Cancer<\/strong><\/td><td><strong>Early \/ Typical Symptoms<\/strong><\/td><\/tr><\/thead><tbody><tr><td>Endometrial (Uterine) Cancer<\/td><td>Post\u2011menopausal or abnormal uterine bleeding<\/td><\/tr><tr><td>Cervical Cancer<\/td><td>Post\u2011menopausal bleeding, foul\u2011smelling vaginal discharge, post\u2011coital bleeding<\/td><\/tr><tr><td>Ovarian Cancer<\/td><td>Abdominal bloating or distension, early satiety, loss of appetite, pelvic or abdominal pain (often late presentation)<\/td><\/tr><tr><td>Vaginal Cancer<\/td><td>Vaginal bleeding, discharge<\/td><\/tr><tr><td>Vulvar Cancer<\/td><td>Chronic pruritus, ulcerated or bleeding lesions, sometimes mimicking dermatologic conditions<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<p>Early recognition of these signs is crucial for timely diagnosis and treatment.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Our Treatment Approach<\/strong><\/h2>\n\n\n\n<p><\/p>\n\n\n\n<figure class=\"wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio\"><div class=\"wp-block-embed__wrapper\">\n<p class=\"responsive-video-wrap clr\"><iframe loading=\"lazy\" title=\"\u201cRobotic Gynecologic Cancer Surgery Explained: Early Signs, Treatment Options\" width=\"1200\" height=\"675\" src=\"https:\/\/www.youtube.com\/embed\/dx4BzkqbaOQ?feature=oembed\" frameborder=\"0\" allow=\"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share\" referrerpolicy=\"strict-origin-when-cross-origin\" allowfullscreen><\/iframe><\/p>\n<\/div><\/figure>\n\n\n\n<p><\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>Surgery \u2013 The Cornerstone<\/strong><\/h3>\n\n\n\n<p><br>Surgical resection is the primary treatment for early\u2011stage gynecologic cancers. The extent of surgery depends on the organ involved, disease stage, and the need for clear oncologic margins.<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Uterine (Endometrial) Cancer<\/strong> \u2013 Total hysterectomy with bilateral salpingo\u2011oophorectomy (TSO) is standard; for higher\u2011risk disease, a <em>radical hysterectomy<\/em> (type\u202fI or type\u202fII) with parametrial resection is performed.<\/li>\n\n\n\n<li><strong>Cervical Cancer<\/strong> \u2013 Radical hysterectomy (type\u202fIII) with pelvic lymphadenectomy is indicated for early stages (IA\u2011IB).<\/li>\n\n\n\n<li><strong>Ovarian Cancer<\/strong> \u2013 Comprehensive staging surgery includes TSO, omentectomy, peritoneal washings, and pelvic\/para\u2011aortic lymph node assessment.<\/li>\n\n\n\n<li><strong>Vaginal &amp; Vulvar Cancers<\/strong> \u2013 Wide local excision or radical vaginectomy\/ vulvectomy with appropriate nodal assessment.<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>Adjuvant Therapy<\/strong><\/h3>\n\n\n\n<p><br>Post\u2011operative pathology guides the need for adjuvant chemotherapy, radiotherapy, or combined chemoradiation. High\u2011risk pathological features (e.g., deep myometrial invasion, lymph\u2011vascular space invasion, positive nodes) often mandate systemic therapy.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>Lymph Node Evaluation<\/strong><\/h3>\n\n\n\n<p>Accurate nodal staging is pivotal because nodal status is a powerful prognostic factor and influences adjuvant treatment decisions.<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Traditional Approach<\/strong> \u2013 Complete pelvic (and when indicated, para\u2011aortic) lymphadenectomy. While thorough, it carries risks of vascular, ureteric, and nerve injury, as well as lymphedema.<\/li>\n\n\n\n<li><strong>Sentinel Lymph Node (SLN) Mapping<\/strong> \u2013 Minimally invasive technique that identifies the first draining nodes. Using indocyanine green (ICG) dye and the <em>Firefly<\/em> imaging system on the DaVinci\u00ae robotic platform, SLNs are visualized in real time. Intra\u2011operative frozen section analysis determines nodal status; a negative SLN can obviate the need for full lymphadenectomy, thereby reducing morbidity without compromising oncologic safety.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Latest &amp; Advanced Robotic Surgery \u2013 Advantages Over Conventional Techniques<\/strong><\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><td><strong>Feature<\/strong><\/td><td><strong>Conventional Laparoscopy<\/strong><\/td><td><strong>Robotic (DaVinci\u00ae)<\/strong><\/td><\/tr><\/thead><tbody><tr><td>Visualization<\/td><td>2\u2011D optics<\/td><td>3\u2011D high\u2011definition<\/td><\/tr><tr><td>Instrument Articulation<\/td><td>Limited (90\u00b0)<\/td><td>Wristed instruments with 7\u00b0 of freedom<\/td><\/tr><tr><td>Ergonomics<\/td><td>Surgeon fatigue common<\/td><td>Comfortable seated console; tremor filtration<\/td><\/tr><tr><td>Learning Curve<\/td><td>Steep for complex pelvic work<\/td><td>Shortened for complex dissection (e.g., radical hysterectomy)<\/td><\/tr><tr><td>Outcomes<\/td><td>Small incisions, modest blood loss<\/td><td>Even less blood loss, precise margin control, reduced conversion rates<\/td><\/tr><tr><td>Recovery<\/td><td>Hospital stays 2\u20114\u202fdays<\/td><td>Hospital stays often \u2264\u202f2\u202fdays; faster return to normal activities<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<p>Robotic platforms enable the surgeon to perform meticulous dissection around critical structures (<strong>ureters, pelvic vasculature, nerves<\/strong>) with enhanced precision. This is especially valuable in:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Radical hysterectomy<\/strong> \u2013 Enabling thorough parametrial and vaginal cuff removal while preserving surrounding neurovascular bundles.<\/li>\n\n\n\n<li><strong>Pelvic lymphadenectomy \/ SLN mapping<\/strong> \u2013 Facilitating delicate exposure of nodal basins and accurate fluorescent imaging.<\/li>\n\n\n\n<li><strong>Ovarian cancer staging<\/strong> \u2013 Allowing comprehensive peritoneal evaluation and omentectomy through small ports.<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>Pre\u2011operative Assessment<\/strong><\/h3>\n\n\n\n<p>All patients undergo a thorough work\u2011up that includes:<\/p>\n\n\n\n<ol class=\"wp-block-list\">\n<li><strong>Radiologic Staging<\/strong> \u2013 MRI of the pelvis (and CT\/PET\u2011CT when indicated) to delineate tumor extent and nodal involvement.<\/li>\n\n\n\n<li><strong>Laboratory Evaluation<\/strong> \u2013 CBC, renal and hepatic panels, tumor markers (CA\u2011125 for ovarian lesions).<\/li>\n\n\n\n<li><strong>Multidisciplinary Review<\/strong> \u2013 Presentation at tumor board to finalize the surgical plan and anticipate adjuvant therapy needs.<\/li>\n<\/ol>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>Clinical Outcomes<\/strong><\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Oncologic Adequacy<\/strong> \u2013 Robotic surgery achieves comparable (and often superior) negative\u2011margin rates and nodal yields to open surgery.<\/li>\n\n\n\n<li><strong>Morbidity <\/strong>\u2013 Decreased intra\u2011operative blood loss, lower transfusion rates, and reduced postoperative pain.<\/li>\n\n\n\n<li><strong>Functional Recovery<\/strong> \u2013 Shorter hospital stay, faster return to daily activities, and lower incidence of lymphedema when SLN mapping is employed.<\/li>\n\n\n\n<li><strong>Survival<\/strong> \u2013 Long\u2011term disease\u2011free survival mirrors that of traditional approaches, affirming the oncologic safety of minimally invasive techniques.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Conclusion<\/strong><\/h2>\n\n\n\n<p>Gynecologic cancers require a nuanced, multidisciplinary approach. Surgery remains the cornerstone of curative therapy, and when performed with modern robotic technology, it offers superior precision, reduced morbidity, and rapid recovery without compromising oncologic outcomes.<\/p>\n\n\n\n<p>If you or a loved one are facing a diagnosis of a gynecologic malignancy, our team\u2014led by Dr. Parminder Kaur\u2014stands ready to provide comprehensive evaluation, <strong>state\u2011of\u2011the\u2011art<a href=\"https:\/\/drmandeepsinghmalhotra.com\/robot-assisted-gynec-oncology-surgery.html\"> robotic surgery in Delhi NCR<\/a>,<\/strong> and coordinated adjuvant care. We invite you to contact our Patient Care Coordinator&nbsp; at (+91 99714 74985)&nbsp; to discuss personalized treatment options and to schedule a consultation.<\/p>\n\n\n\n<p><\/p>\n","protected":false},"excerpt":{"rendered":"<p>An Overview of Gynecologic Cancers, Their Management and the Role of Robotic Surgery in Delhi NCR India About Dr Parminder Kaur Dr. Parminder Kaur&nbsp; is a recent addition to&nbsp; Dr Mandeep&#8217;s team. She is a certified gynecologic oncologist in Delhi NCR with extensive experience in both conventional and laproscopic surgery. Dr Mandeep has mentored her [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":139,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1,18,60,6],"tags":[12,9,55,53,21,58,57,56,7,59,54,16],"class_list":["post-137","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-blog","category-cervical-cancer","category-robotic-gynecologic-cancer-surgery","category-robotic-surgery","tag-cervical-cancer","tag-dr-mandeep-s-malhotra","tag-gynecologic-cancers","tag-gynecologic-oncology","tag-oncologist-in-delhi-ncr","tag-ovarian-cancer-staging","tag-pelvic-lymphadenectomy","tag-radical-hysterectomy","tag-robotic-breast-cancer-surgery","tag-robotic-surgeon","tag-robotic-surgery-center","tag-targeted-therapy","entry","has-media"],"_links":{"self":[{"href":"https:\/\/drmandeepsinghmalhotra.com\/blogs\/wp-json\/wp\/v2\/posts\/137","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/drmandeepsinghmalhotra.com\/blogs\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/drmandeepsinghmalhotra.com\/blogs\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/drmandeepsinghmalhotra.com\/blogs\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/drmandeepsinghmalhotra.com\/blogs\/wp-json\/wp\/v2\/comments?post=137"}],"version-history":[{"count":2,"href":"https:\/\/drmandeepsinghmalhotra.com\/blogs\/wp-json\/wp\/v2\/posts\/137\/revisions"}],"predecessor-version":[{"id":142,"href":"https:\/\/drmandeepsinghmalhotra.com\/blogs\/wp-json\/wp\/v2\/posts\/137\/revisions\/142"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/drmandeepsinghmalhotra.com\/blogs\/wp-json\/wp\/v2\/media\/139"}],"wp:attachment":[{"href":"https:\/\/drmandeepsinghmalhotra.com\/blogs\/wp-json\/wp\/v2\/media?parent=137"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/drmandeepsinghmalhotra.com\/blogs\/wp-json\/wp\/v2\/categories?post=137"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/drmandeepsinghmalhotra.com\/blogs\/wp-json\/wp\/v2\/tags?post=137"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}